Skip to main content

Bioceres Crop Solutions Corp.

For the period ended May 12, 2026. Filed May 12, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

May 12, 2026 · Filed May 12, 2026

Use the contents to explore the available documents and sections.

BIOX$0.23+10.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Table 6: Capitalization and Debt

**Table 6:**Capitalization and Debt

(In millions of U.S. dollars)As of March, 31
20252026
Total Debt
Short-Term Debt181.1174.7
Long-Term Debt75.754.1
Cash and Cash Equivalents(38.5)(14.4)
Other short-term investments(0.9)(0.5)
Debt net of cash, cash equivalents and other short-term investments217.4214.0

Total Financial Debt stood at $228.8 million as of March 31, 2026, broadly stable compared to the preceding quarter.

6BIOCERES CROP SOLUTIONSTHIRD QUARTER 2026

As previously discussed, following the acceleration notices associated with the noteholders dispute, substantially all of the related notes — $108.3 million — remain classified as short-term debt. The dispute subsequently led to the January 2026 foreclosure auction involving the Pro Farm Group, which had a significant impact on the Company’s consolidated balance sheet and equity position.

The transaction resulted in the derecognition and reclassification of approximately $194 million of net assets associated with the PFG business, including substantial reductions in goodwill and intangible assets, together with the recognition of a related non-cash accounting loss during the second quarter of fiscal 2026.

The acceleration of the notes and foreclosure auction continue to be disputed by the Company and remain subject to ongoing legal proceedings.

Beyond the noteholders’ litigation, the Company continued advancing liability management initiatives across the rest of the organization during the quarter. In Argentina, Rizobacter continued progressing discussions with banking partners regarding the reprofiling of debt obligations, reaching agreements covering a substantial portion of bank debt maturities. In parallel, the Company launched a voluntary maturity extension process for local bond obligations.

Cash, Cash Equivalents and Other Short-term Investments totaled $14.8 million at quarter end. During the period, management remained focused on working capital discipline, tighter cash management and improving collection dynamics across the business. The resulting Net Financial Debt was $214.0 million as of March 31, 2026, stable compared to $216.0 million in the prior-quarter (2Q26).

7BIOCERES CROP SOLUTIONSTHIRD QUARTER 2026
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.